Skip to content

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00308477
Enrollment
Unknown
Registered
2006-03-29
Start date
Unknown
Completion date
Unknown
Last updated
2012-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Branch Retinal Vein Occlusion, Macular Degeneration, Macular Edema

Keywords

eye diseases

Brief summary

This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone for the treatment of macular edema associated with branch retinal vein occlusion.

Interventions

DRUGdexamethasone

Sponsors

Sanwa Kagaku Kenkyusho Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Macular edema resulting from branch retinal vein condition * The criteria for visual acuity and macular thickness are met

Exclusion criteria

* History of glaucoma * Diabetic retinopathy * Known steroid-responder * Use of systemic steroids * Use of Warfarin/Heparin

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026